No Data
No Data
Earnings Preview: GeoVax Labs to Report Financial Results Post-market on March 27
WHO Maintains Public Health Emergency Alert on Mpox
GeoVax Anticipates Significant 2025 Progress With Catalyst-Rich Milestones Across Key Programs
GeoVax Announces Strategic Integration Of AI In Support Of President Trump's Stargate Initiative; Harnessing AI To Revolutionize Vaccine And Therapy Development
GeoVax Shares Update On Its Advanced MVA Manufacturing Process, Aimed To Enhance Vaccine Supply Worldwide
GeoVax Labs to Initiate Phase 2 Clinical Study of Gedeptin
Unlock the Full List